Abstract
Natural Killer (NK) cells are cytotoxic effector lymphocytes with the ability to lyse target cells in a major histocompatibility complex (MHC) class I-independent manner and without the need for prior antigen exposure. Data strongly suggested that NK cells play an important role in human reproduction and disturbance in their function can favor development of the gynecological disorders. In our study the role of NK cells in pathogenesis of endometriosis is reviewed and summarized from available literature. Endometriosis is related to a defect of NK cell cytotoxicity function in the ability to eliminate endometrial cells in ectopic sites. Alternations of the innate immunity mediated by NK cells may promote impairments or disrupt functions of adaptive immunity, which can contribute to development and progression of endometriosis and infertility associated with endometriosis. Aberrant immune responses by NK cells in affected women may represent risk factors for endometriosis and the repaired function can be a new treatment target of the affected women.
Keywords: Cytokines, endometriosis, NK cells, peritoneal fluid, Natural Killer, major his-tocompatibility complex (MHC), innate immunity, granular lymphocytes, histocompati-bility complex, hematopoietic stem cells, perforins, gran-zymes, immuno-globulin class G (IgG), interferon (IFN), chemoattractant protein 1, immunoglobulin, immunoregulatory, endometrium, dysmenorrhea, ectopic sites, gonadotropin-releasing hormone agonist (GnRH), laparoscopic surgery, polymorphism, matrix metalloproteinase, IFN-gene, danazol, paclitaxel, carboplatin, 5-fluorouraci, malignant melanoma, immunomodulatory activ-ity, mycobacterium vaccination, endometrioid heterotopies
Current Medicinal Chemistry
Title: Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis
Volume: 18 Issue: 2
Author(s): Justyna Sikora, Aleksandra Mielczarek-Palacz and Zdzislawa Kondera-Anasz
Affiliation:
Keywords: Cytokines, endometriosis, NK cells, peritoneal fluid, Natural Killer, major his-tocompatibility complex (MHC), innate immunity, granular lymphocytes, histocompati-bility complex, hematopoietic stem cells, perforins, gran-zymes, immuno-globulin class G (IgG), interferon (IFN), chemoattractant protein 1, immunoglobulin, immunoregulatory, endometrium, dysmenorrhea, ectopic sites, gonadotropin-releasing hormone agonist (GnRH), laparoscopic surgery, polymorphism, matrix metalloproteinase, IFN-gene, danazol, paclitaxel, carboplatin, 5-fluorouraci, malignant melanoma, immunomodulatory activ-ity, mycobacterium vaccination, endometrioid heterotopies
Abstract: Natural Killer (NK) cells are cytotoxic effector lymphocytes with the ability to lyse target cells in a major histocompatibility complex (MHC) class I-independent manner and without the need for prior antigen exposure. Data strongly suggested that NK cells play an important role in human reproduction and disturbance in their function can favor development of the gynecological disorders. In our study the role of NK cells in pathogenesis of endometriosis is reviewed and summarized from available literature. Endometriosis is related to a defect of NK cell cytotoxicity function in the ability to eliminate endometrial cells in ectopic sites. Alternations of the innate immunity mediated by NK cells may promote impairments or disrupt functions of adaptive immunity, which can contribute to development and progression of endometriosis and infertility associated with endometriosis. Aberrant immune responses by NK cells in affected women may represent risk factors for endometriosis and the repaired function can be a new treatment target of the affected women.
Export Options
About this article
Cite this article as:
Sikora Justyna, Mielczarek-Palacz Aleksandra and Kondera-Anasz Zdzislawa, Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis, Current Medicinal Chemistry 2011; 18 (2) . https://dx.doi.org/10.2174/092986711794088416
DOI https://dx.doi.org/10.2174/092986711794088416 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Current Pharmaceutical Design Editorial [Hot Topic: Development of Drugs Interfering with Apoptosis (Executive Guest Editor: Sebastiano Cavallaro)]
Current Pharmaceutical Design Determination of Specificity and Biochemical Characteristics of Neutral Protease Isolated from Myceliophthora thermophila
Protein & Peptide Letters Systems Cytogenomics: Are We Ready Yet?
Current Genomics Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Cancer Therapy Reviews Nanoparticles in Melanoma
Current Medicinal Chemistry Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody
Anti-Cancer Agents in Medicinal Chemistry Superparamagnetic Magnetite (Fe3O4) Nanoparticles for Bio-Applications
Recent Patents on Materials Science The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
Current Pharmaceutical Design Neurokinin-1 Receptor Antagonists as Anticancer Drugs
Letters in Drug Design & Discovery Neuroprotective Gene Therapy for Parkinson’s Disease
Current Gene Therapy Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics Has Bevacizumab (Avastin) Given Extra Therapeutic Gain in Metastatic Colorectal Cancer and Malignant Brain Gliomas? Systematic Review Answering this Question
Recent Patents on Inflammation & Allergy Drug Discovery Differentiation Potential of Human Retinoblastoma Cells
Current Pharmaceutical Biotechnology Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery